NCT07012590View on ClinicalTrials.gov

Morphine and Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound-guided Erector Spinae Plane Block for Open Subcostal Renal Surgeries

NACompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
MorphineDexmedetomidineAdjuvantsBupivacaineUltrasoundErector Spinae Plane BlockOpen Subcostal Renal Surgeries
Interventions
DRUG

Morphine

Patients received erector spinae plane block with morphine 2 mg as an adjuvant to bupivacaine 30 ml 0.25%.

DRUG

Dexmedetomidine

Patients received erector spinae plane block with dexmedetomidine 100 µg as an adjuvant to bupivacaine 30 ml 0.25%.

OTHER

Erector spinae plane block

Patients received erector spinae plane block with bupivacaine 30 ml 0.25% only.

Trial Locations (1)

33516

Kafrelsheikh University, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER

NCT07012590 - Morphine and Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound-guided Erector Spinae Plane Block for Open Subcostal Renal Surgeries | Biotech Hunter | Biotech Hunter